INTRODUCTION: Evidence based treatment for Substance use disorders (SUD) includes psychotherapy and pharmacotherapy. However, these are only partially effective. Hallucinogens, such as psilocybin, may represent potential new treatment options for SUD. This review provid... View more
1. Degenhardt L, Whiteford HA, Ferrari AJ, et al. Global burden of disease attributable to illicit drug use and dependence: findings from the global burden of disease study 2010. Lancet. 2013;382 (9904):1564-1574.
2. Weiss RD, Griffin ML, Mirin SM. Drug abuse as self-medication for depression: an empirical study. Am J Drug Alcohol Abuse. 1992;18 (2):121-129.
3. Cornelius JR, Maisto SA, Pollock NK, et al. Rapid relapse generally follows treatment for substance use disorders among adolescents. Addict Behav. 2003;28(2):381-386.
4. American Psychiatric Association. 2013. Diagnostic and statistical manual of mental disorders, fifth edition. 5th ed.
5. Volkow ND, Li T-K. Science and society - Drug addiction: the neurobiology of behaviour gone awry. Nat Rev Neurosci. 2004;5 (12):963-970.
6. Dailly E, Chenu F, Renard CE, et al. Dopamine, depression and antidepressants. Fundam Clin Pharmacol. 2004;18(6):601-607.
7. Swendsen JD, Merikangas KR. The comorbidity of depression and substance use disorders. Clin Psychol Rev. 2000;20(2):173-189.
8. Howell LL, Cunningham KA. Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder. Pharmacol Rev. 2015;67(1):176-197.
9. Cools R, Roberts AC, Robbins TW. Serotoninergic regulation of emotional and behavioural control processes. Trends Cogn Sci. 2008;12(1):31-40.
10. Müller CP, Homberg JR. The role of serotonin in drug use and addiction. Behav Brain Res. 2015;277:146-192.